...
首页> 外文期刊>Oncology research and treatment. >Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis (vol 41, pg 450, 2018)
【24h】

Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis (vol 41, pg 450, 2018)

机译:在HER2阳性转移性乳腺癌中的曲妥珠替省治疗中的整体存活益处:回顾性分析(Vol 41,PG 450,2018)

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Oncology research and treatment.》 |2018年第10期|共1页
  • 作者单位

    Capital Med Univ Beijing Shijitan Hosp Dept Breast Ctr Beijing Peoples R China;

    Capital Med Univ Beijing Friendship Hosp Med &

    Hlth Ctr Beijing Peoples R China;

    Liaoning Canc Hosp &

    Inst Dept Internal Oncol Shenyang Liaoning Peoples R China;

    China Japan Friendship Hosp Dept Oncol Beijing Peoples R China;

    Shandong Canc Hosp Dept Oncol Jinan Shandong Peoples R China;

    Nanjing Med Univ Affiliated Hosp 1 Dept Oncol Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Jiangsu Canc Hosp Dept Oncol Nanjing Jiangsu Peoples R China;

    Capital Med Univ Beijing Shijitan Hosp Dept Breast Ctr Beijing Peoples R China;

    Capital Med Univ Beijing Shijitan Hosp Dept Breast Ctr Beijing Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号